ALB and lung cancer: The surprise question and general clinical (age, male sex, disease stage, performance status, comorbidity, cognitive impairment, (sub)cutaneous metastases, and lung cancer) and laboratory variables (serum albumin and hemoglobin) are non-tumor specific predictors of mortality within 3–24 months in patients with advanced cancer.